UnknownNot Applicable

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

Italy180 participantsStarted 2017-11

Plain-language summary

Study purpose is to evaluate treatment outcome and survival in patient with aggressive lymphomas transformed from Follicular Lymphoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Histologically confirmed transformed Follicular Lymphoma * Age \> 18 years * Histological transformation between January 2002 and December 2014 * Availability of data about treatment and outcome Exclusion Criteria: * Other lymphoma diagnosis

What they're measuring

Progression Free Survival

Timeframe: From first response to last follow-up for at least 2 years (up to 15 years)

Overall Survival

Timeframe: Date of last follow-up for at least 2 years (up to 15 years)

Trial details

NCT IDNCT02927756

SponsorA.O.U. Città della Salute e della Scienza

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-05

Contact for this trial

Barbara Botto, MD

+390116334553 bbotto@cittadellasalute.to.it

View on ClinicalTrials.gov More Non-Hodgkin Lymphoma Transformed Recurrent trials